Manufacturers should demonstrate that any new technology or method not just meets the present requirements for sterility assurance but additionally delivers tangible Positive aspects with regard to efficiency, reliability, or products safety. As these new systems emerge, the WHO emphasizes the significance of a radical threat evaluation and validation Successfully Submitted (Awaiting Approval)